MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Body position during sleep in patients with Parkinson’s disease (PD): A sensor-based analysis

    J. Sringean, P. Taechalertpaisarn, C. Thanawattano, R. Bhidayasiri (Nonthaburi, Thailand)

  • Body weight determinants in Parkinson’s disease: A multifactorial study

    A. Bril, M. Rossi, S. Fariña, P. Morisset, L. Sorrentino, M. Iglesias, A. Medina Escobar, P. Millar Vernetti, D. Cerquetti, S. Perez Lloret, M. Merello (Buenos Aires, Argentina)

  • Botulinum neurotoxin type A versus anticholinergics for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update

    F.B. Rodrigues, G.S. Duarte, R.E. Marques, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

  • Botulinum neurotoxin type A versus placebo for hemifacial spasm in adults – 2016 Cochrane movement disorders group systematic review update

    M. Castelão, F.B. Rodrigues, R.E. Marques, G.S. Duarte, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

  • Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update

    M. Castelão, G.S. Duarte, F.B. Rodrigues, R.E. Marques, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

  • Botulinum toxin A injections changes sensorimotor network activations in cervical dystonia to state more related to physiological condition

    M. Nevrly, P. Hlustik, P. Otruba, P. Hok, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)

  • Botulinum toxin in cerebral palsy children with gait disorder: Different therapy approaches

    G.S. Pilina (Izhevsk, Russia)

  • Botulinum toxin treatment of freezing of gait in Parkinson’s disease patients as reflected in functional magnetic resonance imaging of leg movement

    M. Vaštík, P. Hok, P. Hluštík, P. Kanovský, Z. Tüdös (Olomouc, Czech Republic)

  • Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis

    R.E. Marques, G.S. Duarte, F.B. Rodrigues, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

  • Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis

    R.E. Marques, G.S. Duarte, F.B. Rodrigues, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 207
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley